Prof. Dwight Stoll Receives Thought Leader Award From Agilent Technologies
Gustavus Chemistry Professor Dwight Stoll. Gustavus Adolphus College
Agilent Technologies Inc. announced today that Prof. Dwight Stoll has received an Agilent Thought Leader Award in support of his research applying two-dimensional liquid chromatography (2D-LC) to biopharmaceutical analysis.
An influential researcher in chromatography, Prof. Stoll specializes in multi-dimensional separations, which enables scientists to isolate the components of complex samples with greater ease and clarity.
“I am honored to receive this award, and very excited about Agilent’s support of the vision of my laboratory and our collaborators, as we focus on the development of next-generation analytical tools based on 2D-LC for the biopharmaceutical research area,” said Prof. Stoll, associate professor of analytical chemistry at Gustavus Adolphus College in Saint Peter, Minnesota.
Prof. Stoll will lead a project on the use of 2D-LC in biopharmaceutical analysis that includes several international experts: Prof. Michael Lämmerhofer of the University of Tuebingen, Germany; Dr. Douglas Richardson of Merck Research Laboratories, Kenilworth, NJ, USA; and Dr. Davy Guillarme of the University of Geneva, Switzerland.
“We are pleased to support Dr. Stoll’s research using Agilent’s transformative 2D-LC technology, which has the potential to resolve key challenges that biopharmaceutical scientists face when analyzing complex samples,” said Dr. Stefan Schuette, vice president and general manager Liquid Phase Separations Division at Agilent Technologies. “The collaborative nature of the research of Dr. Stoll and his international colleagues, combining both academia and industry, will undoubtedly accelerate the progress of these types of solutions for the biopharma industry.”
Schuette noted that the high separation power of Agilent’s 2D-LC technology makes it ideal for the analysis of highly complex biopharmaceuticals, whether used for comprehensive screening or detailed determination of specific peptides.
The Agilent Technologies Thought Leader Award promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences, diagnostics and applied chemical markets. Information about previous award recipients is available by visiting the Agilent Thought Leader Program web page.
This article has been republished from materials provided by Agilent Technologies Inc.. Note: material may have been edited for length and content. For further information, please contact the cited source.
Boyds Acquires New Cambridge Office to Support Rapid GrowthNews
Boyds, the drug development consultancy which helps pharmaceutical companies translate great science into marketable medicines for patient benefit, has relocated into new premises in Cambridge.READ MORE
Metrohm Acquires Innovative Photonic Solutions to Expand Handheld Raman PortfolioNews
With this important acquisition, Metrohm continues to invest in strategic growth and enhances the company’s capabilities to further develop a portfolio of industry-leading Raman solutions.READ MORE
Anti-Inflammatory Pill Could Make Vaccines More Effective for the ElderlyNews
By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.READ MORE